ВЕЛАСКО ДИЕС Гильермо (ES),ГУСМАН ПАСТОР Мануэль (ES),ЛОРЕНТЕ Мар (ES),ТОРРЕС София (ES)
申请号：
RU2010154672/15
公开号：
RU2010154672A
申请日:
2009.06.04
申请国别(地区):
RU
年份:
2012
代理人:
摘要：
1. The combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) in a ratio of 5: 1 to 1: 5 and a non-cannabinoid chemotherapeutic agent for use in the treatment of brain tumors. ! 2. The combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) according to claim 1, where the treatment of a brain tumor is to reduce cell viability, inhibit cell growth or reduce tumor volume. ! 3. The combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) according to claim 1, where the ratio of THC and CBD is from 2: 1 to 1: 2. ! 4. The combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) according to claim 1, where the ratio of THC and CBD is approximately 1: 1. ! 5. The combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) according to claim 1, where the total number of cannabinoids is in the range between 5 and 100 mg. ! 6. The combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) according to claim 1, where the non-cannabinoid chemotherapeutic agent is a selective modulator of the estrogen receptor. ! 7. The combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) according to claim 6, where the selective modulator of the estrogen receptor is selected from the group consisting of: afimoxifene (4-hydroxytamoxifen)； arzoxifene； bazedoxifene； clomiphene； lazofoxifene； oromeloxyphene； raloxifene； tamoxifen and toremifene. ! 8. The combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) according to claim 7, where the selective modulator of the estrogen receptor is one of: raloxifene； tamoxifen and toremifene. ! 9. The combination of cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) according to claim 1,1. Комбинация каннабиноидов тетрагидроканнабинола (ТГК) и каннабидиола (КБД) в соотношении от 5:1 до 1:5 и неканнабиноидного химиотерапевтического агента для применения в лечении опухоли мозга. ! 2. Комб
